IFN-CM1R1-100μg / 询价
IFN-CM1R1-500μg / 询价
IFN-CM1R1-500μgx2 / 询价
- 客服电话
- 技术支持
Cynomolgus IFN alpha/beta R1 Protein
Recombinant Cynomolgus IFN alpha/beta R1 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ala25-Lys437 [Accession | A0A7N9D7J0].
The protein has a predicted MW of 48.54 kDa. Due to glycosylation, the protein migrates to 75-105 kDa based on Bis-Tris PAGE result.
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Less than 1EU per μg by the LAL method.
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
-20 to -80°C for 12 months as supplied from date of receipt.
-80°C for 3 months after reconstitution.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Cynomolgus IFN alpha/beta R1 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Cynomolgus IFN alpha/beta R1 is greater than 95% as determined by SEC-HPLC.
Immobilized Cynomolgus IFN alpha/beta R1, His Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Anti-IFNAR1 Antibody, hFc Tag with the EC50 of 13.2ng/ml determined by ELISA (QC Test).
IFN-alpha / beta R1, also known as IFNAR1, belongs to the class II cytokine receptor family of proteins. Class II cytokine receptors form heterodimeric receptor complexes that mediate class II cytokine signals. Subunits of the different receptor complexes are shared and serve multiple functions.Functions in general as heterodimer with IFNAR2. Type I interferon binding activates the JAK-STAT signaling cascade, and triggers tyrosine phosphorylation of a number of proteins including JAKs, TYK2, STAT proteins and the IFNR alpha- and beta-subunits themselves.
AVP; IFN-alpha/beta R1; IFN-alpha-REC; IFNAR; IFNAR1; IFN-aR1; IFNBR; IFNbR1; IFN-R-1; CRF2-1; IFRC ; IFN-alpha/β R1
(1)Teunissen P F A , Boshuizen M C , Hollander M R , et al. MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden[J]. Cardiovascular Research, 2015, 107(2):255-266.
